These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 8029931)
1. Cytotoxic effects of human preformed anti-Gal IgG and complement on cultured pig cells. Koren E; Kujundzic M; Koscec M; Neethling FA; Richards SV; Ye Y; Zuhdi N; Cooper DK Transplant Proc; 1994 Jun; 26(3):1336-9. PubMed ID: 8029931 [No Abstract] [Full Text] [Related]
2. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817 [TBL] [Abstract][Full Text] [Related]
3. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model. Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844 [TBL] [Abstract][Full Text] [Related]
5. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells. Winand RJ; Anaraki F; Etienne-Decerf J; Galili U J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224 [TBL] [Abstract][Full Text] [Related]
6. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation. Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404 [No Abstract] [Full Text] [Related]
7. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies. Yu PB; Holzknecht ZE; Bruno D; Parker W; Platt JL J Immunol; 1996 Dec; 157(11):5163-8. PubMed ID: 8943428 [TBL] [Abstract][Full Text] [Related]
9. Efficiency of different synthetic oligosaccharides for blocking the natural anti-g Gal antibodies found in human and baboon sera. Oriol R; Neethling F; Joziasse D; Bovin N; Cooper DK Transplant Proc; 1996 Apr; 28(2):562. PubMed ID: 8623272 [No Abstract] [Full Text] [Related]
10. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs. Baumann BC; Stussi G; Huggel K; Rieben R; Seebach JD Transplantation; 2007 Jan; 83(2):193-201. PubMed ID: 17264816 [TBL] [Abstract][Full Text] [Related]
11. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation. Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564 [TBL] [Abstract][Full Text] [Related]
12. Capture of anti-(Galalpha1-3Gal) antibodies by immobilized Galalpha1-3Gal oligomers derived from carrageenan. Klein E; Euler M; Vercellotti J Biotechnol Appl Biochem; 1998 Dec; 28 ( Pt 3)():189-99. PubMed ID: 9799716 [TBL] [Abstract][Full Text] [Related]
13. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. Wright A; Morrison SL J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299 [TBL] [Abstract][Full Text] [Related]
16. Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes. Pitre J; Möller E; Satake M Transplant Proc; 1996 Apr; 28(2):545. PubMed ID: 8623257 [No Abstract] [Full Text] [Related]
17. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose. LaTemple DC; Henion TR; Anaraki F; Galili U Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064 [TBL] [Abstract][Full Text] [Related]
18. In silico analysis of antibody-carbohydrate interactions and its application to xenoreactive antibodies. Agostino M; Sandrin MS; Thompson PE; Yuriev E; Ramsland PA Mol Immunol; 2009 Dec; 47(2-3):233-46. PubMed ID: 19828202 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the human alpha 1,3Gal-reactive natural antibody population. McMorrow IM; Comrack C; Sachs DH; Monroy R; DerSimonian H Transplant Proc; 1996 Apr; 28(2):547. PubMed ID: 8623259 [No Abstract] [Full Text] [Related]
20. Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies. Cairns T; Hammelmann W; Gray D; Welsh K; Larson G Transplant Proc; 1994 Jun; 26(3):1279-80. PubMed ID: 7518125 [No Abstract] [Full Text] [Related] [Next] [New Search]